You are viewing a single thread.
View all comments The drug was being pushed into trials by its manufacturer, Cassava Sciences, but a group of scientists who reviewed the drug makerโs claims about Simufilam believed that it was exaggerating the potential. So they did what any reasonable person would do: They purchased short sell positions in Cassava Sciences stock
This is not what reasonable people do.